tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Cara Therapeutics Completes Merger with Tvardi Therapeutics

Story Highlights
  • Cara Therapeutics merged with Tvardi Therapeutics, forming a Nasdaq-listed company.
  • The merger positions Tvardi to advance clinical programs with data readouts expected in 2025 and 2026.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Cara Therapeutics Completes Merger with Tvardi Therapeutics

Confident Investing Starts Here:

The latest announcement is out from Cara Therapeutics ( (CARA) ).

On April 15, 2025, Cara Therapeutics completed its merger with Tvardi Therapeutics, resulting in the formation of a Nasdaq-listed company named Tvardi Therapeutics, Inc. The merger, accompanied by a reverse stock split and a private placement financing, positions Tvardi to advance its clinical programs targeting fibrosis-driven diseases, with anticipated data readouts in 2025 and 2026. The merger also involved a significant restructuring of the company’s board and management, aligning with Tvardi’s strategic focus.

Spark’s Take on CARA Stock

According to Spark, TipRanks’ AI Analyst, CARA is a Neutral.

Cara Therapeutics is currently facing significant financial difficulties, with declining revenues and persistent losses weighing heavily on its prospects. However, the technical indicators show positive momentum, and the strategic merger with Tvardi Therapeutics offers a potential path to future growth and improvement in market positioning. The poor valuation remains a concern, but the merger could help address financial stability issues.

To see Spark’s full report on CARA stock, click here.

More about Cara Therapeutics

Tvardi Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company is conducting Phase 2 clinical trials in idiopathic pulmonary fibrosis and hepatocellular carcinoma.

YTD Price Performance: 3.53%

Average Trading Volume: 21,063

Technical Sentiment Signal: Buy

Current Market Cap: $25.38M

Find detailed analytics on CARA stock on TipRanks’ Stock Analysis page.

OSZAR »

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Market News >

More Articles

More News >

Stock Comparison

Quantum ComputingAICryptocurrencyBitcoin StocksDividendValueBiotechOilChineseChat GPTBanksAirlineBeer & BeveragesEnergy

Investment Ideas

Analyst Top StocksSmart Score StocksStock ScreenerTop Wall Street AnalystsInsiders' Hot StocksTop Penny StocksUnusual Options ActivityTop ETFs by Upside Potential

Trending Articles:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' \\n \\n Best Online Brokers\\n \\n , and find the ideal broker for your trades.

Report an Issue

\",\"date\":\"2025-04-15T20:31:57.000Z\",\"description\":\"The latest announcement is out from Cara Therapeutics ( ($CARA) ). On April 15, 2025, Cara Therapeutics completed its merger with Tvardi Therapeutics, resulting in the formation of a Nasdaq-listed\\n\",\"image\":{\"src\":\"https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2068435553-750x406.jpg\",\"width\":750,\"height\":406},\"keywords\":[\"AI\",\"stock split\"],\"link\":\"/news/company-announcements/cara-therapeutics-completes-merger-with-tvardi-therapeutics\",\"mainMarket\":\"us\",\"slug\":\"cara-therapeutics-completes-merger-with-tvardi-therapeutics\",\"sticky\":false,\"storyHighlights\":\"\\n\",\"thumbnail\":{\"src\":\"https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2068435553-150x150.jpg\"},\"title\":\"Cara Therapeutics Completes Merger with Tvardi Therapeutics\",\"topics\":[{\"id\":0,\"type\":null,\"market\":null,\"title\":\"8K\",\"slug\":\"8k\",\"sentiment\":null,\"isVisible\":true,\"displayTitle\":\"8K\"},{\"id\":0,\"type\":\"stock\",\"market\":\"us\",\"title\":\"CARA\",\"slug\":\"cara\",\"sentiment\":null,\"isVisible\":true,\"displayTitle\":\"CARA\"},{\"id\":0,\"type\":\"stock\",\"market\":\"ch\",\"title\":\"CH:69C\",\"slug\":\"ch69c\",\"sentiment\":null,\"isVisible\":true,\"displayTitle\":\"69C\"},{\"id\":0,\"type\":\"stock\",\"market\":\"de\",\"title\":\"DE:69C0\",\"slug\":\"de69c0\",\"sentiment\":null,\"isVisible\":true,\"displayTitle\":\"69C0\"},{\"id\":0,\"type\":\"stock\",\"market\":\"uk\",\"title\":\"GB:0HTC\",\"slug\":\"gb0htc\",\"sentiment\":null,\"isVisible\":true,\"displayTitle\":\"0HTC\"},{\"id\":0,\"type\":null,\"market\":null,\"title\":\"DATA-CAT-SPLIT\",\"slug\":\"data-cat-split\",\"sentiment\":null,\"isVisible\":false,\"displayTitle\":\"DATA-CAT-SPLIT\"},{\"id\":0,\"type\":null,\"market\":null,\"title\":\"DATA-CAT-DELISTING\",\"slug\":\"data-cat-delisting\",\"sentiment\":null,\"isVisible\":false,\"displayTitle\":\"DATA-CAT-DELISTING\"},{\"id\":0,\"type\":null,\"market\":null,\"title\":\"DATA-CAT-BOARDCHANGE\",\"slug\":\"data-cat-boardchange\",\"sentiment\":null,\"isVisible\":false,\"displayTitle\":\"DATA-CAT-BOARDCHANGE\"},{\"id\":0,\"type\":null,\"market\":null,\"title\":\"DATA-SENTIMENT-POSITIVE\",\"slug\":\"data-sentiment-positive\",\"sentiment\":null,\"isVisible\":false,\"displayTitle\":\"DATA-SENTIMENT-POSITIVE\"},{\"id\":0,\"type\":null,\"market\":null,\"title\":\"DATA-CAT-MARGER-ACQUISITION\",\"slug\":\"data-cat-marger-acquisition\",\"sentiment\":null,\"isVisible\":false,\"displayTitle\":\"DATA-CAT-MARGER-ACQUISITION\"},{\"id\":0,\"type\":null,\"market\":null,\"title\":\"DATA-CAT-PLACEMENT-FINANCING\",\"slug\":\"data-cat-placement-financing\",\"sentiment\":null,\"isVisible\":false,\"displayTitle\":\"DATA-CAT-PLACEMENT-FINANCING\"}],\"words\":246,\"timeAgo\":\"1M\",\"time\":1744749117000,\"badge\":null,\"id\":1919195,\"languages\":{\"es\":{\"link\":\"https://es.tipranks.com/news/company-announcements/cara-therapeutics-completa-fusion-con-tvardi-therapeutics\"}},\"seo\":{\"title\":\"Cara Therapeutics Completes Merger with Tvardi Therapeutics\",\"description\":\"

The latest announcement is out from Cara Therapeutics ( ($CARA) ). On April 15, 2025, Cara Therapeutics completed its merger with Tvardi Therapeutics, resulting in ...\"},\"linkToVideo\":null,\"callToActionType\":\"design\"},\"relatedLinks\":null},\"isLoadedFromSSR\":true}}");

OSZAR »